The SLC12A6 gene helps nerve cells control their salt and water balance, which supports normal signaling and cell shape. If this gene does not work properly, nerves can become damaged over time, leading to weakness, numbness, trouble with balance or walking, and sometimes developmental or learning differences. Certain disease-causing variants in the SLC12A6 gene are linked to a rare inherited condition called Andermann syndrome. Many other variants in this gene have little or no effect.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which do much of the cell’s work. Others are involved mainly in controlling when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they may also influence how you react to food, stress, or medicines. For a deeper look at this topic, you can find more in the LearnHub.
Overview
SLC12A6Gene function
What if the gene works
The SLC12A6 gene helps nerve cells move potassium and chloride. This supports normal cell volume and steady signaling in the brain and peripheral nerves.
Risk
What if the gene does not work
Pathogenic variants in the SLC12A6 gene can cause an inherited nerve condition with weakness and reduced sensation, often alongside an absent or underdeveloped connection between the brain’s halves. Milder and more severe variants can affect timing and severity.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided specifically by a pathogenic variant in the SLC12A6 gene. The SLC12A6 gene is being studied through its protein, KCC3, as a possible target for future nerve therapies, but this has not led to guideline-based medicines.
Conditions associated with SLC12A6
Gene function
What if the gene works
Your cells use the SLC12A6 gene to manage key salts and water. Its protein sits in the cell membrane and moves potassium and chloride together from one side to the other. This helps cells keep a steady size and supports normal nerve function.
The SLC12A6 gene gives cells instructions for a transport protein that moves potassium and chloride together across the cell membrane. This steady flow helps keep the cell’s inner salt balance on track.
When a cell takes in extra water and starts to swell, the SLC12A6 gene helps the cell shift salts outward. Water follows that movement, which helps the cell return toward its usual size.
In nerve cells, balanced chloride levels help signals stay well controlled. This supports everyday communication in the brain, spinal cord, and peripheral nerves.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. Sometimes, though, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC12A6 gene can alter the KCC3 transport protein so it folds poorly, is unstable, fails to reach the cell membrane, or moves potassium and chloride less effectively. This is how SLC12A6 gene variants affect protein function in cells. Milder variants may leave some transport activity, while more severe variants can greatly reduce or eliminate it, which often lines up with earlier or more marked nerve problems.
How variants are linked to conditions
Pathogenic variants in the SLC12A6 gene can cause Andermann syndrome, a hereditary nerve condition often seen with absent or partly formed tissue connecting the two sides of the brain. Some SLC12A6 gene variants linked to conditions are also associated with Charcot-Marie-Tooth disease or related inherited neuropathies, which can affect walking, balance, and strength. The exact features can vary from person to person and depend on the specific variant.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors play a role. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC12A6-related conditions, risk mainly depends on the gene change you inherit, especially when both parents carry a harmful variant. Family history and whether parents are carriers are the main things that change risk. There is not enough evidence to say that diet, exercise, or other lifestyle factors lower the chance of developing the condition.
Inheritance of SLC12A6 variants
The inheritance of the SLC12A6 gene variants can differ depending on the specific condition involved. Well-established SLC12A6-related neuropathy with agenesis of the corpus callosum usually follows an autosomal recessive pattern, which means a child inherits one altered copy from each parent. Some other SLC12A6-related conditions have been reported with autosomal dominant inheritance, where one altered copy can be enough, and in those families each child has a 50% chance of inheriting it. This means SLC12A6 inheritance is not described by a single pattern for every condition.
What does my SLC12A6 result mean for my family?
For family members, the meaning of an SLC12A6 result depends on the exact change and the condition linked to it. Some SLC12A6-related conditions are passed down in a recessive way, so brothers and sisters may also be affected or may be healthy carriers, while parents are often carriers. A smaller number follow a dominant pattern, which can mean a parent, child, or sibling may also carry the variant.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for SLC12A6 variants looks for changes in the SLC12A6 gene using a blood sample or saliva sample. The lab reads the gene’s DNA code and may also check for missing or extra pieces. Results can show whether a variant is present, though they do not always predict symptoms or how strongly a person may be affected.
When should I consider getting a genetic test?
Genetic testing for the SLC12A6 gene may be considered if someone has early nerve problems such as weakness, trouble walking, loss of feeling in the feet and hands, or a brain scan showing missing or underdeveloped tissue connecting the two sides of the brain. It can also help when these problems run in a family.
A genetic result is only one part of your health story
Genetic findings can be informative, yet the amount they reveal varies with the condition and the specific variant. Over time, many factors, including lifestyle, surroundings, age, and medical history, influence how the body functions. In some conditions, particularly those shaped by many genes, genetic information offers context instead of certainty and makes the most sense when considered with the rest of a person’s care. In other situations, a genetic result can give a clear answer. For topics like medication response, genetic results may help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, moves, breaks down, or responds to a drug. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else. These differences are common and are one of several factors that shape medication response.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the response to medications. It studies connections between genes and drugs to better explain why treatments do not work the same way for every person. With many medicines, genes help shape both how strongly a drug works and how the body processes it. This information can support more informed, more individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the SLC12A6 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so questions about medicines, side effects, or interactions are best discussed with your doctor.
History
Throughout history, people have described features that hinted at this gene. In French Canadian families from Quebec, clinicians recognized a recurring inherited nerve condition with changes in brain development long before its genetic cause was known. Initially understood only through visible traits, later recognized as tied to a specific gene, this pattern became known as Andermann syndrome. From these first observations, research expanded steadily, and in the early 2000s scientists linked the condition to variants in the SLC12A6 gene. That discovery helped confirm the condition’s inherited basis and connected earlier family studies with modern genetic testing. Over time, descriptions became more precise as researchers identified additional SLC12A6 variants in people outside the original founder population.